Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement
23 oct. 2024 09h00 HE
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc., today announced that results from its study of gildeuretinol in geographic atrophy were presented at AAO 2024.
Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
22 oct. 2024 07h05 HE
|
Clearside Biomedical, Inc.
- CLS-AX Phase 3 Ready Based on Positive Phase 2b Topline Data in Wet AMD - - Differentiated Profile for CLS-AX Targeting Flexible Dosing Similar to a Biologic with the Potential Extended Duration of...
Alkeus Pharmaceuticals Announces Data Presentations at the American Academy of Ophthalmology (AAO) 2024 Annual Meeting, October 18-21 in Chicago
17 oct. 2024 08h29 HE
|
Alkeus Pharmaceuticals
Results from Study of Oral Gildeuretinol for Geographic Atrophy Secondary to Age-Related Macular Degeneration to be Presented as Late-Breaker During Retina Subspecialty Day Positive Data from TEASE...
Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
07 nov. 2023 16h20 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting
02 nov. 2023 07h05 HE
|
Clearside Biomedical, Inc.
Clearside Biomedical announced that multiple oral & poster presentations will be delivered at the American Academy of Ophthalmology (AAO) 2023 Annual Mtg.
EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023
31 oct. 2023 09h55 HE
|
EyeMD EMR Healthcare Systems, Inc.
EyeMD EMR Healthcare Systems Inc. Announces the Release of Axon Patient Engagement at AAO 2023
Nextech to Highlight Ophthalmology Solution Innovations at AAO Conference
30 oct. 2023 10h42 HE
|
Nextech Systems, Inc.
Nextech will showcase transformative innovations to its ophthalmology industry-leading software at the AAO 2023 conference from Nov. 3-6.
Iantrek reports two upcoming American Academy of Ophthalmology presentations of its breakthrough glaucoma surgical technologies, including 1-year results of a novel supraciliary outflow micro-interventional procedure
16 oct. 2023 08h00 HE
|
Iantrek, Inc.
Biotech startup to present 12 month data for novel Glaucoma treatment at AAO.
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
04 oct. 2022 07h05 HE
|
Clearside Biomedical, Inc.
- Favorable Safety Profiles and Encouraging Efficacy Data Reported in Clinical Trials in the Suprachoroidal Space (SCS®) Across Multiple Therapeutic Areas using Clearside’s SCS Microinjector® - - SCS...
eSight™ Assistive Device for Visually Impaired Available for Demonstrations at AAO
20 sept. 2022 09h00 HE
|
eSight
CHICAGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Leading vision enhancement platform, eSight, is holding demonstrations of its current medical device model, eSight 4, at the American Academy of...